-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our 12-month target price by $100 to $1,220, valuing BLK shares at 22x our 2026 adjusted EPS estimate of $54.58 (raised by $0.38) and at 20x our 2027 EPS estimate of $61.75. Our target multiples compare to BLK's one-year average forward multiple of 21x and a peer average of 13x, which included many firms that are slower growing and less profitable than BLK. Despite a challenging macroeconomic and geopolitical environment, we believe BLK shares are poised to outperform, thanks to a combination of solid, above-peer organic AUM growth, a growing and recurring revenue stream from technology services operations, and contributions from a targeted acquisition program. Currently trading at 19x our 2026 EPS estimate and at 17x our 2027 EPS estimate and yielding 2.2%, we view the shares as undervalued versus historical averages.